Syringes Market Size was valued at USD 18.1 Billion in 2022. The Syringes industry is projected to grow from USD 19.7 Billion in 2023 to USD 38.98 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2023 - 2032). The development of healthcare facilities, especially in emerging markets, and Increased awareness among healthcare professionals and patients about the importance of safe injection practices are expected to be a significant market driver for the Syringes Market.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Market CAGR for Syringes is being driven by the Prevalence of chronic diseases like Type-1 Diabetes and hypertension and the Usage of syringes in COVID-19 and other infectious diseases like Hepatitis B vaccination. The rise in the prevalence of chronic diseases, such as type-1 diabetes or Insulin Dependent Diabetes Mellitus (IDDM), has become increasingly notable. As per the International Diabetes Federation, around 537 million adults (20-79 years) will be living with diabetes in 2021, and this number is expected to reach 643 million by 2030 and 783 million by 2045. A significant portion of adults with diabetes resides in low- and middle-income countries, with nearly 240 million cases going undiagnosed. In 2021, diabetes resulted in 6.7 million deaths. Currently, insulin remains the primary treatment option for IDDM, administered subcutaneously or occasionally intravenously using specialized syringes known as insulin syringes. Even for type-2 diabetes patients in emergency and resistant cases, insulin remains the sole option. Consequently, the prevalence of chronic diseases is a pivotal factor driving the growth of the syringe market.
Vaccines, crucial for preventing infectious diseases and developing immunity, particularly in children, are biological preparations. Measles vaccines alone, as per the United Nations International Children's Emergency Fund (UNICEF), are estimated to have prevented approximately 21 million deaths between 2000-2017. The majority of vaccines are administered through syringes, playing a vital role in immunizing children against fatal and untreatable infections. UNICEF, being the largest member to purchase auto-disposable syringes, contributes significantly to the market, making vaccines a paramount factor propelling the syringes market.
As a result, it is anticipated that throughout the projection period, demand for the Syringes Market will increase due to the Prevalence of chronic diseases like Type-1 Diabetes, Hypertension and Usage of syringes in COVID-19 and other infectious disease like Hepatitis B vaccination. Thus, driving the Syringes Market revenue.
The Syringes Market segmentation, based on Usability includes Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safe, prefilled). The Disposable Syringes segment dominated the market, accounting for 58% of market revenue. The widespread availability of sterilized, cost-effective, and ready-to-use single-use syringes has created significant market potential for disposable syringes. The increasing concern about disease transmission associated with reusable syringes has fueled the demand for disposable alternatives, particularly among healthcare professionals. Additionally, the ready availability of raw materials for manufacturing disposable syringes makes them an ideal choice for adoption.
The Syringes Market segmentation, based on Material includes Glass Syringes and Plastic Syringes. The Plastic Syringes segment dominated the market, accounting for 58% of market revenue (10.4 Billion). The growth of the plastic syringes segment in the market is propelled by factors such as an escalating awareness regarding blood-borne infections and a growing preference for self-administration. These trends contribute to increased adoption of plastic syringes as they offer a safer and more user-friendly option, aligning with the rising emphasis on healthcare safety and the individual's ability to self-administer medications.
Figure 1: Syringes Market, by Material, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Syringes Market segmentation, based on Type includes General Syringes and specialized Syringes (Insulin Syringes, Tuberculin Syringes, Allergy Syringes, Other Syringes). The specialized Syringes segment dominated the market, accounting for 60% of market revenue. Specialized syringes are pivotal in facilitating drug delivery systems, and responding to the advancements in pharmaceuticals, biotechnology, and personalized medicine. The increasing need is for syringes capable of handling intricate drug formulations, high-viscosity medications, or those demanding precise dosage control.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The anticipated expansion of the Syringes market in North America can be attributed to several key factors. The surge in chronic diseases and the growing demand for vaccinations, which heavily rely on syringes, particularly single-use and disposable ones, are bolstering the market. As per the International Diabetes Federation (IDF) Diabetics Atlas, the diabetic population is projected to increase by 46.0%, reaching 643 million (1 in 9 adults) by 2030. This growth is expected to be more pronounced in middle-income countries compared to developed nations. Additionally, the market is propelled by the adoption and advancement of disposable medical supplies aimed at preventing infections during hospital procedures.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SYRINGES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe Syringes Market accounts for the second-largest market share as the demand for syringes in diverse healthcare settings is anticipated to rise, particularly due to the increasing aging population, which is more vulnerable to chronic conditions like diabetes and lifestyle-related disorders. For instance, as per Statistics Sweden (SCB), the proportion of people aged 80 and above is expected to increase by 50% by 2028. Another contributing factor is the imperative to curb the spread of diseases such as HIV. Unsafe disposal practices of syringes have been a significant factor in the high incidence of HIV. Adhering to safe injection procedures is crucial in preventing the contamination and transmission of HIV, thereby fueling the growth of the industry. For instance, the World Health Organization (WHO) estimated that in 2021, approximately 38.4 million individuals worldwide were affected by HIV. Additionally, around 107,000 people in the European Region were diagnosed with HIV in 2022, with approximately 17,000 in the EU/EEA region. Further, the German Syringes Market held the largest market share, and the UK Syringes Market was the fastest-growing market in the European region
The Asia-Pacific Syringes Market is expected to grow at the fastest CAGR from 2023 to 2032.
The increasing trend among consumers to opt for innovative and advantageous products with minimal associated risks has created additional opportunities for emerging regions like India. Boasting a population of 1.39 billion, India is recognized as one of the swiftly growing economies globally. The initiation of numerous vaccination campaigns by the Indian government aimed at safeguarding the community from health issues has contributed positively to the rise in per capita healthcare spending, thereby fostering the growth of the syringes market in India. The onset of the pandemic has also emerged as a significant factor driving the expansion of the syringes market in the country. Moreover, China’s Syringes Market held the largest market share, and the Indian Syringes Market was the fastest-growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development to expand their product lines, which will help the Syringes market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the syringe industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Syringes industry to benefit clients and increase the market sector. In recent years, the syringe industry has offered some of the most significant advantages to the healthcare sector. Major players in the Syringes Market, including Becton, Dickinson, and Company (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), Smiths Medical (U.S.), B. Braun Medical Inc. (U.S.), NIPRO Corporation (Japan), Hindustan Syringes & Medical Devices Limited (India), Gerresheimer AG (Germany), SCHOTT AG (Germany), and CODAN Medizinische Geräte GmbH & Co KG (Germany) are attempting to increase market demand by investing in research and development operations.
Becton Dickinson and Company, a medical technology company, specializes in manufacturing and selling a range of medical devices, reagents, and instruments. Its diverse product portfolio includes syringes and pen needles, intravenous catheters, infusion pumps, disposables, automated medication dispensing systems, pre-fillable drug delivery systems, respiratory ventilation equipment, diagnostic tools, and more. BD caters to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industries, and the general public. The company has a presence, marketing its products in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Headquartered in New Jersey, USA, BD introduced the BD Intevi 1mL two-step disposable autoinjector in October 2019. This innovative device seamlessly combines an autoinjector and a pre-fillable syringe in one integrated system, offering a new generation of autoinjectors designed to enhance drug administration and simplify self-injection for patients
Terumo Corporation is a manufacturer and distributor of medical care products, specializing in hospital and medical equipment. The company's extensive range of product categories includes pharmaceuticals, blood bags, disposable medical devices, nutritional supplements, cardiovascular systems, vascular grafts, blood glucose monitoring systems, medical electronics, peritoneal dialysis, and digital thermometers. Terumo's products are applied in therapies conducted within blood vessels, as well as in cardiac and vascular surgeries. Additionally, the company operates blood centers that collect and process blood to meet transfusion needs. Terumo has a presence, with subsidiaries and associates in Europe, North America, South America, Asia Pacific, the Middle East, and Africa. The company is headquartered in Shibuya-ku, Tokyo, Japan. In October 2022, Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation, introduced a ready-to-fill polymer syringe designed for challenging biotech drugs with larger volumes. The PLAJEX 2.25 mL with Tapered Needle is specifically tailored to address the needs of the biotech market, making it suitable for complex drug applications, including high-viscosity biotech medications.
Becton, Dickinson, and Company (U.S.)
Terumo Corporation (Japan)
Medtronic plc (Ireland)
Smiths Medical (U.S.)
B. Braun Medical Inc. (U.S.)
NIPRO Corporation (Japan)
Hindustan Syringes & Medical Devices Limited (India)
Gerresheimer AG (Germany)
SCHOTT AG (Germany)
CODAN Medizinische Geräte GmbH & Co KG (Germany)
September 2019: In September 2019, Braun Melsungen, in partnership with Royal Philips, introduced the Vision Needle Tip Tracking, a technology designed to ensure precise needle positioning within the body. This innovation assists anesthesiologists in safely and effectively conducting anesthesia procedures, particularly in avoiding complications related to peripheral nerve blocks
December 2020: In December 2020, Smiths Medical introduced the Echoglo needle for peripheral nerve block procedures. This needle features a combination of clockwise and counter-clockwise grooves, strategically designed to reflect acoustic energy to the transducer, thereby enhancing echogenic visibility during medical procedures
Sterilizable/reusable (hypodermic, oral)
Disposable Syringes (conventional, safety, prefilled)
Glass Syringes
Plastic Syringes
General Syringes
Specialized Syringes (Insulin Syringes, Tuberculin Syringes, Allergy Syringes, Other Syringes)
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 18.1 Billion |
| Market Size 2023 | USD 19.7 Billion |
| Market Size 2032 | USD 38.98 Billion |
| Compound Annual Growth Rate (CAGR) | 8.90% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Usability, Material, Type, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Becton, Dickinson, and Company (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), Smiths Medical (U.S.), B. Braun Medical Inc. (U.S.), NIPRO Corporation (Japan), Hindustan Syringes & Medical Devices Limited (India), Gerresheimer AG (Germany), SCHOTT AG (Germany), and CODAN Medizinische Geräte GmbH & Co KG (Germany) |
| Key Market Opportunities | The emphasis by the safety bodies and governments on the prevention of the reuse of syringes |
| Key Market Dynamics | The increasing prevalence of chronic diseases, and advancements in syringe materials |
Syringes Market Highlights:
Frequently Asked Questions (FAQ) :
The Syringes Market size was valued at USD 18.1 Billion in 2022
The Syringes Market is projected to grow at a CAGR of 8.90% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Becton, Dickinson, and Company (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), Smiths Medical (U.S.), B. Braun Medical Inc. (U.S.), NIPRO Corporation (Japan), Hindustan Syringes & Medical Devices Limited (India), Gerresheimer AG (Germany), SCHOTT AG (Germany), and CODAN Medizinische Geräte GmbH & Co KG (Germany).
The Disposable Syringes segment dominated the market in 2022.
The specialized Syringes segment had the largest share in the market.
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
